Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel

BACKGROUND: Today, more than 70% of patients with primary node-negative breast cancer are cured by local therapy alone. Many patients receive overtreatment by adjuvant chemotherapy due to inadequate risk assessment. So far, few clinical trials have prospectively evaluated tumor biology based prognos...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Kantelhardt, Eva J, Vetter, Martina, Schmidt, Marcus, Veyret, Corinne, Augustin, Doris, Hanf, Volker, Meisner, Christoph, Paepke, Daniela, Schmitt, Manfred, Sweep, Fred, von Minckwitz, Gunter, Martin, Pierre-Marie, Jaenicke, Fritz, Thomssen, Christoph, Harbeck, Nadia
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BioMed Central 2011
Θέματα:
Study Protocol
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3089797/
https://ncbi.nlm.nih.gov/pubmed/21496284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-140
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια